about
Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis.Impact of pharmacists as immunizers on influenza vaccination coverage in Nova Scotia, Canada.Routine immunization of adults by pharmacists: Attitudes and beliefs of the Canadian public and health care providers.Impact of pharmacists as immunizers on influenza vaccination coverage in the community-setting in Nova Scotia, Canada: 2013-2015.Impact of pharmacist administration of influenza vaccines on uptake in Canada.Is there a role for therapeutic drug monitoring of vitamin D level as a surrogate marker for fracture risk?Identification of the relationship between barriers and facilitators of pharmacist prescribing and self-reported prescribing activity using the theoretical domains framework.The impact of pharmacists as immunizers in Collaborative cOmmunity Offsite Pharmacy Practice (CO-OPP Phase 1).Patient experiences with influenza immunizations administered by pharmacists.Pharmacy-initiated immunizations in the emergency department-HaliVax PIIE.Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.Pharmacists as immunizers: a survey of community pharmacists’ willingness to administer adult immunizationsKnowledge, attitudes, behaviours, and beliefs of healthcare provider students regarding mandatory influenza vaccinationEvidence for pharmacist vaccinationPharmacists' immunization experiences, beliefs, and attitudes in New Brunswick, CanadaPharmacist-led intervention to improve medication use in older inpatients using the Drug Burden Index: a study protocol for a before/after intervention with a retrospective control group and multiple case analysisMedication-related criteria in frailty assessment tools: A narrative reviewPharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significanceOpportunities for pharmacists to recommend and administer routine vaccines
P50
Q36169950-BF2C9332-46C6-44C4-A273-04CF657453D1Q37131028-F41A246C-EC51-45DE-A15E-08BC708B0900Q37135000-FF776B12-CD16-42DE-8893-C90B4F5C4AECQ37349946-B240A0C3-4DAC-49D2-A288-B3372438D5ABQ37606990-F9EE302A-1A56-4FED-9C95-65850A9814DDQ37697776-2354062C-C922-4646-94B0-2D007D570648Q47588311-7E6D4B71-499B-44E5-967E-8EB5FEFDF54EQ48275767-1D90342F-07AC-4B5D-9EB5-7EA2AE380CA8Q48303853-6C94E9E3-2FAE-4DDF-B58A-3DD8CB6876F5Q55248975-432E7CC4-24B4-476A-8EC0-553B632D6153Q55512620-128A4E6A-FA2A-46BF-83B2-97F213DEB1CFQ58217837-364E9A2A-835C-4F28-A715-3528A5D44928Q58610346-36401CFD-97B3-44E6-BDD0-57FDEB9CB0FFQ59343036-EF80A85E-6D78-46BF-8D22-85F7B253CC4AQ60944582-2A1BEDBA-6231-46C1-B2B4-C7CD156CF095Q89837920-CE9FD710-BC96-473A-9856-0BBB4B365E65Q89928971-189AF9DA-FDA5-4031-96A3-40DD08AF4455Q90608951-FFD6AD85-6A8A-4E2B-8798-ADDB6AF03994Q91427737-BD588294-1595-4FA7-81B0-598B3B136EF8
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jennifer Isenor
@ast
Jennifer Isenor
@en
Jennifer Isenor
@es
Jennifer Isenor
@nl
type
label
Jennifer Isenor
@ast
Jennifer Isenor
@en
Jennifer Isenor
@es
Jennifer Isenor
@nl
prefLabel
Jennifer Isenor
@ast
Jennifer Isenor
@en
Jennifer Isenor
@es
Jennifer Isenor
@nl
P106
P1153
35724336700
P21
P31
P496
0000-0003-1648-7362